PALI (Palisade Bio, Inc.) Bathi saben saham sajrone patang kuartal pungkasan

palisadebio.com (PALI) - logo korporat

The daily price action of the year-over-year rolling EPS chart for Palisade Bio, Inc. (PALI) correlates with the progress of the LB1148 candidate in the therapy of gastrointestinal adhesions. Future revenues are based on the development of anti-inflammatory treatments for the intestines, although a lack of pricing power makes the parameter value of 94.20 dependent on regulatory verdicts and clinical trial outcomes.

PALI - Bathi resik saben saham (EPS TTM) Palisade Bio ing rentang 11.02.2024 - 15.11.2026

Palisade Bio Inc. - rincian analitis lan metrik utama (PALI)

- rega pasar lan target rega analis:
Bagan bursa Palisade Bio, Inc.|PALI - Target konsensus
- indikator valuasi pasar bisnis:
Nilai pasar Palisade Bio, Inc.|PALI - Nilai Total Perusahaan
- rincian valuasi buku bisnis:
Nilai Buku Saham Palisade Bio|PALI - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku palisadebio.com|PALI - Aset Agregat Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Palisade Bio, Inc.|PALI - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal palisadebio.com|PALI - Utang perusahaan|Utang-utang marang aset resik Palisade Bio|PALI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Palisade Bio|Rasio likuiditas darurat palisadebio.com
- statistik bathi lan rasio pasar:
PALI - Bathi resik|Bathi resik sing dikarepake Palisade Bio, Inc.|PALI - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Palisade Bio|PALI - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Palisade Bio|PALI - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Palisade Bio|PALI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan palisadebio.com|PALI - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Palisade Bio, Inc.
- indikator dodolan lan pendapatan:
PALI - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan palisadebio.com|PALI - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Palisade Bio|PALI - Wutah dodolan YoY (TTM)
Analisis wiwitan perusahaan:PALI (Palisade Bio)
Barang unggulan Palisade Bio

The margin of safety for Palisade Bio, Inc. (PALI) is determined by the dynamics of its ability to generate earnings per share. The AI-driven robotization of chemical target selection must translate into cost reductions. The analysis of the year-over-year EPS (TTM) metric on GURU.Markets measures the net profit growth rate over the year. A positive trend confirms the efficiency of laboratory automation. This asset belongs to the high-risk biopharmaceutical sector.

Analisis pesaing Palisade Bio, Inc.

Bathi resik saben saham sajrone patang kuartal pungkasan Phathom Corp PHAT|TERN (Terns Pharmaceuticals, Inc.) - Bathi resik saben saham sajrone 12 wulan pungkasan|IRWD: Bathi saben saham sajrone patang kuartal pungkasan|CURX (curanexpharma.com) - Bathi resik saben saham (EPS TTM)|immuron.com.au (IMRN) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham sajrone 12 wulan pungkasan EVOK (Evoke Pharma)|Entero - Bathi saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) RDHL (redhillbio.com)|Bathi resik saben saham sajroning taun lumaku Jaguar Health, Inc.|BIOR - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben siji saham sajrone 12 wulan pungkasan MORF